Dr. Reddy`s Laboratories (RDY) EBITDA (2014 - 2026)
Dr. Reddy`s Laboratories (RDY) EBITDA from Dec 31, 2014 to Mar 31, 2026. The TTM Dr. Reddy`s Laboratories (RDY) EBITDA is $845M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Dr. Reddy`s Laboratories (RDY) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -24.99% |
| 3 Years TTM | +52.50% |
| 5 Years TTM | +23.99% |
| 10 Years TTM | +3.14% |
| All Time TTM | +2.93% |
Annual EBITDA change of Dr. Reddy`s Laboratories (RDY)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $755M | -33.32% |
| 2025 | $1.13B | +6.69% |
| 2024 | $1.06B | +17.14% |
| 2023 | $906M | +52.57% |
| 2022 | $594M | +8021.46% |
| 2021 | $7.31M | -98.68% |
| 2020 | $555M | +8.03% |
| 2019 | $514M | +41.54% |
| 2018 | $363M | -5.00% |
| 2017 | $382M | -36.50% |
| 2016 | $602M | +9.15% |
| 2015 | $551M | +258.00% |
| 2014 | $154M | N/A |
Comparison Dr. Reddy`s Laboratories (RDY) five years EBITDA CAGR with competitors
Dr. Reddy`s Laboratories (RDY) five years EBITDA CAGR is 14.79%.